Abstract
Australia’s suicide rates have been largely unchanged for decades, despite multiple suicide prevention strategies, several national mental health plans, new mood disorder–specific national organisations (e.g. Beyond Blue) and rising antidepressant use (Jorm, 2019). The National Suicide Prevention Trial (NSPT) (2016–2021) was the latest such trial, funded by the Australian Government (Page et al., 2023). Conducted over 12 regional sites across Australia, its aim was to develop individualised suicide prevention strategies targeting specific at-risk demographic groups.
| Original language | English |
|---|---|
| Pages (from-to) | 94-96 |
| Number of pages | 3 |
| Journal | Australian and New Zealand Journal of Psychiatry |
| Volume | 58 |
| Issue number | 1 |
| Early online date | Mar 2023 |
| DOIs | |
| Publication status | Published - Jan 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Suicide
- Hospital Admissions
- Self-Harm
- Australia
Fingerprint
Dive into the research topics of 'Letter to the Editor: Letter to the Editor regarding ‘Early impacts of the “National Suicide Prevention Trial” on trends in suicide and hospital admissions for self-harm in Australia’'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver